Catheter Precision, Inc. (NYSEAMERICAN:VTAK) Short Interest Up 54.0% in February

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) was the recipient of a large increase in short interest in February. As of February 15th, there was short interest totalling 126,400 shares, an increase of 54.0% from the January 31st total of 82,100 shares. Currently, 1.7% of the company’s stock are sold short. Based on an average daily volume of 328,300 shares, the days-to-cover ratio is currently 0.4 days.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Catheter Precision stock. Warberg Asset Management LLC raised its stake in Catheter Precision, Inc. (NYSEAMERICAN:VTAK) by 362.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 310,164 shares of the company’s stock after acquiring an additional 243,164 shares during the period. Warberg Asset Management LLC owned 3.51% of Catheter Precision worth $140,000 as of its most recent SEC filing. Institutional investors and hedge funds own 20.34% of the company’s stock.

Catheter Precision Stock Down 9.0 %

VTAK stock traded down $0.03 during mid-day trading on Monday, hitting $0.32. 124,490 shares of the company were exchanged, compared to its average volume of 407,592. The company has a debt-to-equity ratio of 0.12, a current ratio of 0.66 and a quick ratio of 0.65. Catheter Precision has a twelve month low of $0.31 and a twelve month high of $8.40.

About Catheter Precision

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.